Evidence map›Paper›PMID 41498812›Full record

ArticleHuman genetics2026

Genetic diversity of Usher syndrome in Moroccan patients.

Kenza El Khair, Amale Bousfiha, Aymane Bouzidi, Ghita Amalou, Majida Charif, Hicham Charoute, Adil El Hamouchi, Amina Bakhchane, Khalid Snoussi, Amal Hajjij and 6 more

Abstract read
PubMed Publisher
In one paragraph

Article in Human genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Kenza El KhairGenomics and Human Genetics Laboratory, Institut Pasteur du Maroc, 1 Place Louis Pasteur, 20360, Casablanca, Morocco.ORCID https://orcid.org/0009-0003-9652-8570
Amale BousfihaLaboratory of Integrative Biology, Faculty of Sciences Ain Chock, Hassan II University, Casablanca, Morocco.
Aymane BouzidiInserm, CNRS, MITOVASC, Equipe MitoLab, SFR ICAT, Univ Angers, 49000, Angers, France.
Ghita AmalouGenomics and Human Genetics Laboratory, Institut Pasteur du Maroc, 1 Place Louis Pasteur, 20360, Casablanca, Morocco.
Majida CharifGenetics and Immuno-cell Therapy Team, Mohammed First University, Oujda, Morocco.
Hicham CharouteResearch unit of Epidemiology, Biostatistics and Bioinformatics, Institut Pasteur du Maroc, Casablanca, Morocco.
Adil El HamouchiGenomic Sequencing Laboratory, Institut Pasteur du Maroc, Casablanca, Morocco.
Amina BakhchaneGenomics and Human Genetics Laboratory, Institut Pasteur du Maroc, 1 Place Louis Pasteur, 20360, Casablanca, Morocco.
Khalid SnoussiCentre Mohamed VI de l'audition, Université Mohammed VI des Sciences et de la Santé (UM6SS), Casablanca, Morocco.
Amal HajjijCentre Mohamed VI de l'audition, Université Mohammed VI des Sciences et de la Santé (UM6SS), Casablanca, Morocco.
Mustapha DetsouliGenomics and Human Genetics Laboratory, Institut Pasteur du Maroc, 1 Place Louis Pasteur, 20360, Casablanca, Morocco.
Houda BenrahmaInterdisciplinary Laboratory of Biotechnology and Health, Mohammed VI Higher Institute of Biosciences and Biotechnology, Mohammed VI University of Sciences and Health (UM6SS), Casablanca, Morocco.
Crystel BonnetInstitut Pasteur, AP-HP, Inserm, Fondation pour l'Audition, Institut de l'Audition, IHU reConnect, Université Paris Cité, 75012, Paris, France.
Guy LenaersInserm, CNRS, MITOVASC, Equipe MitoLab, SFR ICAT, Univ Angers, 49000, Angers, France.
Christine PetitInstitut Pasteur, AP-HP, Inserm, Fondation pour l'Audition, Institut de l'Audition, IHU reConnect, Université Paris Cité, 75012, Paris, France.
Abdelhamid BarakatGenomics and Human Genetics Laboratory, Institut Pasteur du Maroc, 1 Place Louis Pasteur, 20360, Casablanca, Morocco. abdelhamid.barakat@pasteur.ma.

Funding

Ministry of Europe and Foreign Affairs, the Ministry of Higher Education, Research and Innovation, and the French Institute of Rabat and the French-Morocco bilateral program PHC TOUBKAL 39005ZL
6 · The paper itself

Abstract

Usher syndrome (USH) is a rare genetic disorder accounting for almost 50% of all hereditary deaf-blindness cases. This heterogeneous, autosomal recessive condition is categorized into 3 main clinical subtypes (USH1, USH2 and USH3) and an atypical form of USH based on the severity and age of onset of the hearing loss, the absence or presence of vestibular dysfunction and the age of retinitis pigmentosa (RP) onset. This study aims to characterize the genetic spectrum of Usher syndrome in the Moroccan population. We used targeted-exome, whole exome and Sanger sequencing to identify variants in USH genes. We identified 25 variants among which 6 novel ones with 22 variants in USH1, 3 in USH2 while none were identified in USH3. Twenty-eight out of 33 families had USH1 and 5 out of 33 had USH2. MYO7A is the most prevalent gene mutated in this study with a recurrent splice acceptor site variant c.2283-1G > T found in 7 families. Our findings contribute to the understanding of the genetic diversity of USH in the Moroccan and North African populations, and emphasize the importance of genetic screening in identifying novel variants and providing an early clinical diagnosis to establish a medical follow-up and genetic counseling.

Indexed as

Genetic VariationUsher SyndromesExtracellular Matrix ProteinsFemaleHumansMaleMoroccoMutationMyosinsMyosin VIIaNorth African PeoplePedigreeExtracellular Matrix ProteinsMYO7A protein, humanMyosinsMyosin VIIa

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.